Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Nov 8;8(1):268.
doi: 10.1186/s13643-019-1187-1.

Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018

Rami H Al-Rifai  1 , Maria Majeed  2 , Maryam A Qambar  3 , Ayesha Ibrahim  3 , Khawla M AlYammahi  3 , Faisal Aziz  2
Affiliations
Meta-Analysis

Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018

Rami H Al-Rifai et al. Syst Rev. .

Abstract

Background: Investing in women's health is an inevitable investment in our future. We systematically reviewed the available evidence and summarized the weighted prevalence of type 2 diabetes (T2DM) and pre-diabetes mellitus (pre-DM) in women of childbearing age (15-49 years) in the Middle East and North African (MENA) region.

Methods: We comprehensively searched six electronic databases to retrieve published literature and prevalence studies on T2DM and pre-DM in women of childbearing age in the MENA. Retrieved citations were screened and data were extracted by at least two independent reviewers. Weighted T2DM and pre-DM prevalence was estimated using the random-effects model.

Results: Of the 10,010 screened citations, 48 research reports were eligible. Respectively, 46 and 24 research reports on T2DM and pre-DM prevalence estimates, from 14 and 10 countries, were included. Overall, the weighted T2DM and pre-DM prevalence in 14 and 10 MENA countries, respectively, were 7.5% (95% confidence interval [CI], 6.1-9.0) and 7.6% (95% CI, 5.2-10.4). In women sampled from general populations, T2DM prevalence ranged from 0.0 to 35.2% (pooled, 7.7%; 95% CI, 6.1-9.4%) and pre-DM prevalence ranged from 0.0 to 40.0% (pooled, 7.9%; 95% CI, 5.3-11.0%). T2DM was more common in the Fertile Crescent countries (10.7%, 95% CI, 5.2-17.7%), followed by the Arab Peninsula countries (7.6%, 95% CI, 5.9-9.5%) and North African countries and Iran (6.5%, 95% CI, 4.3-9.1%). Pre-DM prevalence was highest in the Fertile Crescent countries (22.7%, 95% CI, 14.2-32.4%), followed by the Arab Peninsula countries (8.6%, 95% CI, 5.5-12.1%) and North Africa and Iran (3.3%, 95% CI, 1.0-6.7%).

Conclusions: T2DM and pre-DM are common in women of childbearing age in MENA countries. The high DM burden in this vital population group could lead to adverse pregnancy outcomes and acceleration of the intergenerational risk of DM. Our review presented data and highlighted gaps in the evidence of the DM burden in women of childbearing age, to inform policy-makers and researchers.

Systematic review registration: PROSPERO CRD42017069231.

Keywords: Pre-diabetes mellitus; Type 2 diabetes; Women of childbearing age.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
PRISMA flow chart
Fig. 2
Fig. 2
Forest plot of the meta-analyses for the 14 MENA countries’ studies on T2DM Pooled findings of 102 T2DM prevalence estimates reported in 14 countries in the MENA region. The individual 102 estimates and their 95% confidence interval (CI) omitted to fit the plot. The diamond is centered on the summary effect estimate, and the width indicates the corresponding 95% CI. UAE, United Arab Emirates; T2DM, type 2 diabetes mellitus; MENA, Middle East and Northern Africa
Fig. 3
Fig. 3
Forest plot of the meta-analyses for the 10 MENA countries’ studies on pre-DM pooled findings of 52 pre-DM prevalence estimates reported in 10 countries in the MENA region. The individual 52 estimates and their 95% confidence interval (CI) omitted to fit the plot. The diamond is centered on the summary effect estimate, and the width indicates the corresponding 95% CI. UAE, United Arab Emirates; pre-DM, pre-diabetes mellitus; MENA, Middle East and Northern Africa
See this image and copyright information in PMC

References

    1. International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels: International Diabetes Federation, 2017. https://diabetesatlas.org/resources/2017-atlas.html Accessed 5 Nov 2018.
    1. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, Pratley R, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–759. - PubMed
    1. Forouhi NG, Luan J, Hennings S, Wareham NJ. Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990-2000. Diabet Med. 2007;24(2):200–207. - PubMed
    1. Metcalf PA, Baker JR, Scragg RK, Dryson E, Scott AJ, Wild CJ. Microalbuminuria in a middle-aged workforce. Effect of hyperglycemia and ethnicity. Diabetes Care. 1993;16(11):1485–1493. - PubMed
    1. Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans. The inter-tribal Heart project. J Am Soc Nephrol. 2002;13(6):1626–1634. - PubMed

Publication types